000

LABGEN

No trades
See on Supercharts
Market capitalization
‪201.35 B‬KRW
‪−4.67 B‬KRW
‪73.13 B‬KRW
‪60.84 M‬
Beta (1Y)
1.28

About LABGEN

CEO
Seung-Hyun Jin
Headquarters
Seongnam-si
Employees (FY)
213
Founded
2002
ISIN
KR7084650001
FIGI
BBG004RKW1T8
LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. Its products include sample and bioinformatics analysis, diagnostic checks, and other products. The company was founded on March 29, 2002 and is headquartered in Seongnam-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 084650 is 2740 KRW — it has increased by 0.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange LABGEN stocks are traded under the ticker 084650.
084650 stock is 1.47% volatile and has beta coefficient of 1.28. Check out the list of the most volatile stocks — is LABGEN there?
LABGEN revenue for the last quarter amounts to ‪21.20 B‬ KRW despite the estimated figure of ‪27.70 B‬ KRW. In the next quarter revenue is expected to reach ‪22.30 B‬ KRW.
Yes, you can track LABGEN financials in yearly and quarterly reports right on TradingView.
084650 stock has risen by 8.30% compared to the previous week, the month change is a 15.56% fall, over the last year LABGEN has showed a 11.76% decrease.
084650 net income for the last quarter is ‪−10.85 B‬ KRW, while the quarter before that showed ‪−1.55 B‬ KRW of net income which accounts for −600.50% change. Track more LABGEN financial stats to get the full picture.
Today LABGEN has the market capitalization of ‪201.56 B‬, it has increased by 7.51% over the last week.
Like other stocks, 084650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABGEN stock right from TradingView charts — choose your broker and connect to your account.
084650 reached its all-time high on Jul 31, 2020 with the price of 9635 KRW, and its all-time low was 665 KRW and was reached on Oct 4, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 213.00 employees. See our rating of the largest employees — is LABGEN on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABGEN technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABGEN stock shows the strong sell signal. See more of LABGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LABGEN future price: according to them, 084650 price has a max estimate of 5000.00 KRW and a min estimate of 5000.00 KRW. Read a more detailed LABGEN forecast: see what analysts think of LABGEN and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABGEN EBITDA is ‪−963.82 M‬ KRW, and current EBITDA margin is −1.23%. See more stats in LABGEN financial statements.